Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Feb;91(2):677–683. doi: 10.1172/JCI116248

Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.

H Funke 1, A von Eckardstein 1, P H Pritchard 1, A E Hornby 1, H Wiebusch 1, C Motti 1, M R Hayden 1, C Dachet 1, B Jacotot 1, U Gerdes 1, et al.
PMCID: PMC288009  PMID: 8432868

Abstract

The presence of lecithin:cholesterol acyltransferase (LCAT) deficiency in six probands from five families originating from four different countries was confirmed by the absence or near absence of LCAT activity. Also, other invariate symptoms of LCAT deficiency, a significant increase of unesterified cholesterol in plasma lipoproteins and the reduction of plasma HDL-cholesterol to levels below one-tenth of normal, were present in all probands. In the probands from two families, no mass was detectable, while in others reduced amounts of LCAT mass indicated the presence of a functionally inactive protein. Sequence analysis identified homozygous missense or nonsense mutations in four probands. Two probands from one family both were found to be compound heterozygotes for a missense mutation and for a single base insertion causing a reading frame-shift. Subsequent family analyses were carried out using mutagenic primers for carrier identification. LCAT activity and LCAT mass in 23 genotypic heterozygotes were approximately half normal and clearly distinct from those of 20 unaffected family members. In the homozygous patients no obvious relationship between residual LCAT activity and the clinical phenotype was seen. The observation that the molecular defects in LCAT deficiency are dispersed in different regions of the enzyme suggests the existence of several functionally important structural domains in this enzyme.

Full text

PDF
677

Images in this article

680Image
on p.680

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Adolphson J. L., Chen C. H. Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J Clin Invest. 1981 Jan;67(1):141–148. doi: 10.1172/JCI110006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albers J. J., Utermann G. Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency. Am J Hum Genet. 1981 Sep;33(5):702–708. [PMC free article] [PubMed] [Google Scholar]
  3. Bujo H., Kusunoki J., Ogasawara M., Yamamoto T., Ohta Y., Shimada T., Saito Y., Yoshida S. Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease. Biochem Biophys Res Commun. 1991 Dec 31;181(3):933–940. doi: 10.1016/0006-291x(91)92026-g. [DOI] [PubMed] [Google Scholar]
  4. Dobiásová M. Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport. Adv Lipid Res. 1983;20:107–194. [PubMed] [Google Scholar]
  5. Forte T. M., Nichols A. V., Krauss R. M., Norum R. A. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis. J Clin Invest. 1984 Nov;74(5):1601–1613. doi: 10.1172/JCI111576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frohlich J., Godolphin W. J., Reeve C. E., Evelyn K. A. Familial LCAT deficiency. Report of two patients from a Canadian family of Italian and Swedish descent. Scand J Clin Lab Invest Suppl. 1978;150:156–161. [PubMed] [Google Scholar]
  7. Frohlich J., Hon K., McLeod R. Detection of heterozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Am J Hum Genet. 1982 Jan;34(1):65–72. [PMC free article] [PubMed] [Google Scholar]
  8. Frohlich J., McLeod R., Pritchard P. H., Fesmire J., McConathy W. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. Metabolism. 1988 Jan;37(1):3–8. doi: 10.1016/0026-0495(88)90021-2. [DOI] [PubMed] [Google Scholar]
  9. Funke H., von Eckardstein A., Pritchard P. H., Albers J. J., Kastelein J. J., Droste C., Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4855–4859. doi: 10.1073/pnas.88.11.4855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Funke H., von Eckardstein A., Pritchard P. H., Karas M., Albers J. J., Assmann G. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest. 1991 Jan;87(1):371–376. doi: 10.1172/JCI114997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  12. Gotoda T., Yamada N., Murase T., Sakuma M., Murayama N., Shimano H., Kozaki K., Albers J. J., Yazaki Y., Akanuma Y. Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet. 1991 Sep 28;338(8770):778–781. doi: 10.1016/0140-6736(91)90665-c. [DOI] [PubMed] [Google Scholar]
  13. Gyllensten U. B., Erlich H. A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7652–7656. doi: 10.1073/pnas.85.20.7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klein H. G., Lohse P., Pritchard P. H., Bojanovski D., Schmidt H., Brewer H. B., Jr Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met). J Clin Invest. 1992 Feb;89(2):499–506. doi: 10.1172/JCI115612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kumar R., Barbacid M. Oncogene detection at the single cell level. Oncogene. 1988 Dec;3(6):647–651. [PubMed] [Google Scholar]
  16. Kumar R., Dunn L. L. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncogene Res. 1989;4(3):235–241. [PubMed] [Google Scholar]
  17. Maeda E., Naka Y., Matozaki T., Sakuma M., Akanuma Y., Yoshino G., Kasuga M. Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene. Biochem Biophys Res Commun. 1991 Jul 31;178(2):460–466. doi: 10.1016/0006-291x(91)90129-u. [DOI] [PubMed] [Google Scholar]
  18. McLean J., Wion K., Drayna D., Fielding C., Lawn R. Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res. 1986 Dec 9;14(23):9397–9406. doi: 10.1093/nar/14.23.9397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  20. Polten A., Fluharty A. L., Fluharty C. B., Kappler J., von Figura K., Gieselmann V. Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med. 1991 Jan 3;324(1):18–22. doi: 10.1056/NEJM199101033240104. [DOI] [PubMed] [Google Scholar]
  21. Sandkamp M., Tambyrajah B., Schriewer H., Assmann G. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method. J Clin Chem Clin Biochem. 1988 Nov;26(11):685–688. doi: 10.1515/cclm.1988.26.11.685. [DOI] [PubMed] [Google Scholar]
  22. Skretting G., Prydz H. An amino acid exchange in exon I of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem Biophys Res Commun. 1992 Jan 31;182(2):583–587. doi: 10.1016/0006-291x(92)91772-i. [DOI] [PubMed] [Google Scholar]
  23. Taramelli R., Pontoglio M., Candiani G., Ottolenghi S., Dieplinger H., Catapano A., Albers J., Vergani C., McLean J. Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele. Hum Genet. 1990 Jul;85(2):195–199. doi: 10.1007/BF00193195. [DOI] [PubMed] [Google Scholar]
  24. Utermann G., Menzel H. J., Dieker P., Langer K. H., Fiorelli G. Lecithin-cholesterol-acyltransferase deficiency: autosomal recessive transmission in a large kindred. Clin Genet. 1981 Jun;19(6):448–455. doi: 10.1111/j.1399-0004.1981.tb02063.x. [DOI] [PubMed] [Google Scholar]
  25. Utermann G., Schoenborn W., Langer K. H., Dieker P. Lipoproteins in LCAT-deficiency. Humangenetik. 1972;16(4):295–306. doi: 10.1007/BF00283977. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES